NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

Mr AF,

1) ATL-DC and DCVax are same formulation & process and UCLA makes ATL-DC for their own local use at UCLA because they can and UCLA makes it at UCLA, so it’s faster and simpler than sending tumor to Cognate or Advent to make the vaccine and have to ship it back frozen, etc. Also, UCLA focuses on the research and clinical practice, and would not want to deal with the commercialization, hence the relationship with Northwest Bio.

2) Dr Liau has stated in connection with her recent presentations that ATL-DC is DCVax-L, meaning they are equivalent but the naming goes according to 1) above. Dr Liau’s presentation deck identifies nwbo as a sponsor of the combo trial with Keytruda and the Revimmune IL-7 component.

3) the combo treatment patent lists UCLA, NWBO, Cognate(CRL), and Revimmune as joint inventors (the names are listed for the companies, I.e., Dr Liau, Linda Powers, etc.)

This FUD premise is just that, FUD.